Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:43 UTC |
GROGAN DONNA ROYDirector
|
GrantCommon Stock | 4,618 | $3.14 | $14,500.52 |
DisclosureSEC source: 0001470831-26-000924 · wk-form4_1790973819.xml · nonDerivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,471 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2026. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:43 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 3,662 | $3.14 | $11,498.68 |
DisclosureSEC source: 0001470831-26-000925 · wk-form4_1790973827.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,612 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 1, 2026. Read SEC document |
| September 18, 2026 Filed Sep 21, 2026 20:24 UTC |
Adams KendraChief Financial Officer
|
Tax withholdingCommon Stock | 2,775 | $3.39 | $9,407.25 |
DisclosureSEC source: 0001470831-26-000895 · wk-form4_1790022287.xml · nonDerivative · entry 2 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 382,323 F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| September 18, 2026 Filed Sep 21, 2026 20:24 UTC |
Adams KendraChief Financial Officer
|
Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000895 · wk-form4_1790022287.xml · nonDerivative · entry 1 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on September 19, 2023. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 20:33 UTC |
REYNO LEONARDChief Medical Officer
|
Tax withholdingCommon Stock | 7,397 | $4.06 | $30,031.82 |
DisclosureSEC source: 0001470831-26-000705 · wk-form4_1783974826.xml · nonDerivative · entry 2 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 372,406 F2 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| July 10, 2026 Filed Jul 13, 2026 20:33 UTC |
REYNO LEONARDChief Medical Officer
|
Exercise / conversionCommon Stock | 15,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000705 · wk-form4_1783974826.xml · nonDerivative · entry 1 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of restricted stock units ("RSUs"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on July 12, 2023. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:04 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 2,650 | $4.34 | $11,501.00 |
DisclosureSEC source: 0001470831-26-000688 · wk-form4_1783022665.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,950 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2026. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:04 UTC |
GROGAN DONNA ROYDirector
|
GrantCommon Stock | 3,341 | $4.34 | $14,499.94 |
DisclosureSEC source: 0001470831-26-000689 · wk-form4_1783022677.xml · nonDerivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,853 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on July 1, 2026. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:27 UTC |
Fawell StephenDirector
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001470831-26-000659 · wk-form4_1782505640.xml · derivative · entry 1 Fawell Stephen · CIK 0002033387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 24, 2026 Filed Jun 27, 2026 00:33 UTC |
Hughes OwenDirector
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001470831-26-000673 · wk-form4_1782520384.xml · derivative · entry 1 Hughes Owen · CIK 0001575933 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 24, 2026 Filed Jun 27, 2026 00:26 UTC |
Hoerter Steven L.Director
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001470831-26-000670 · wk-form4_1782520015.xml · derivative · entry 1 Hoerter Steven L. · CIK 0001533451 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:31 UTC |
Koppikar UtpalDirector
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001470831-26-000667 · wk-form4_1782505872.xml · derivative · entry 1 Koppikar Utpal · CIK 0001742696 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:30 UTC |
Anderson Kenneth CarlDirector
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001470831-26-000665 · wk-form4_1782505819.xml · derivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:29 UTC |
Cooper Ronald Harold WilfredDirector
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001470831-26-000663 · wk-form4_1782505765.xml · derivative · entry 1 Cooper Ronald Harold Wilfred · CIK 0001676880 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:28 UTC |
Bessen LauraDirector
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001470831-26-000661 · wk-form4_1782505691.xml · derivative · entry 1 Bessen Laura · CIK 0001926815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 24, 2026 Filed Jun 26, 2026 20:25 UTC |
GROGAN DONNA ROYDirector
|
GrantStock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001470831-26-000657 · wk-form4_1782505541.xml · derivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2036-06-23 F1 · derivative.exercise_date: This option shall vest and become exercisable in full upon the earlier to occur of (i) June 24, 2027 and (ii) the next annual meeting of the Issuer's stockholders, subject to the recipient's continued service as a member of the Board on such date. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 20:14 UTC |
Anderson Kenneth CarlDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,070 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001470831-26-000504 · wk-form4_1780604078.xml · derivative · entry 7 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,070 shares Expires 2026-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise. F7 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable. Read SEC document |
| June 01, 2026 Filed Jun 4, 2026 20:14 UTC |
Anderson Kenneth CarlDirector
|
Exercise / conversionCommon Stock | 1,070 | $2.11 | $2,257.70 |
DisclosureSEC source: 0001470831-26-000504 · wk-form4_1780604078.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction represents the exercise of a stock option for cash. No shares were sold in connection with the exercise. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 14:45 UTC |
Anderson Kenneth CarlDirector
|
GrantCommon Stock | 4,259 | $2.70 | $11,499.30 |
DisclosureSEC source: 0001470831-26-000346 · wk-form4_1775227552.xml · nonDerivative · entry 1 Anderson Kenneth Carl · CIK 0001824862 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,230 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2026. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 14:45 UTC |
GROGAN DONNA ROYDirector
|
GrantCommon Stock | 5,370 | $2.70 | $14,499.00 |
DisclosureSEC source: 0001470831-26-000345 · wk-form4_1775227541.xml · nonDerivative · entry 1 GROGAN DONNA ROY · CIK 0001788455 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,512 F1 · kind: These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer. F2 · price: The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on April 1, 2026. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 22:04 UTC |
Hirsch AndrewDirector · President & CEO
|
Tax withholdingCommon Stock | 9,057 | $1.89 | $17,117.73 |
DisclosureSEC source: 0001470831-26-000177 · wk-form4_1771452294.xml · nonDerivative · entry 5 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,074,934 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 15, 2026 Filed Feb 18, 2026 22:04 UTC |
Hirsch AndrewDirector · President & CEO
|
Exercise / conversionCommon Stock | 20,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000177 · wk-form4_1771452294.xml · nonDerivative · entry 4 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,083,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 15, 2024 and February 18, 2025. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 17:05 UTC |
Boyle Scott NChief Business Officer
|
Tax withholdingCommon Stock | 7,269 | $1.89 | $13,738.41 |
DisclosureSEC source: 0001470831-26-000180 · wk-form4_1771452315.xml · nonDerivative · entry 5 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,801 F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 17:05 UTC |
Boyle Scott NChief Business Officer
|
Exercise / conversionCommon Stock | 20,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000180 · wk-form4_1771452315.xml · nonDerivative · entry 4 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 17:05 UTC |
Mahaney PaigeChief Scientific Officer
|
Tax withholdingCommon Stock | 2,446 | $1.89 | $4,622.94 |
DisclosureSEC source: 0001470831-26-000179 · wk-form4_1771452309.xml · nonDerivative · entry 3 Mahaney Paige · CIK 0002040313 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,910 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 17:05 UTC |
Mahaney PaigeChief Scientific Officer
|
Exercise / conversionCommon Stock | 7,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000179 · wk-form4_1771452309.xml · nonDerivative · entry 2 Mahaney Paige · CIK 0002040313 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of RSUs. The grant of RSUs was initially reported in Table I of the Forms 4 filed by the Reporting Person on February 18, 2025. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:04 UTC |
Mossler MarkChief Accounting Officer
|
Tax withholdingCommon Stock | 3,268 | $1.89 | $6,176.52 |
DisclosureSEC source: 0001470831-26-000174 · wk-form4_1771452272.xml · nonDerivative · entry 3 Mossler Mark · CIK 0001992219 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,916 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:04 UTC |
Mossler MarkChief Accounting Officer
|
Exercise / conversionCommon Stock | 9,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000174 · wk-form4_1771452272.xml · nonDerivative · entry 2 Mossler Mark · CIK 0001992219 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on April 10, 2024 and February 18, 2025. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 17:04 UTC |
Adams KendraChief Financial Officer
|
Tax withholdingCommon Stock | 15,381 | $1.89 | $29,070.09 |
DisclosureSEC source: 0001470831-26-000175 · wk-form4_1771452283.xml · nonDerivative · entry 5 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,098 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 17:04 UTC |
Adams KendraChief Financial Officer
|
Exercise / conversionCommon Stock | 30,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000175 · wk-form4_1771452283.xml · nonDerivative · entry 4 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:04 UTC |
REYNO LEONARDChief Medical Officer
|
Tax withholdingCommon Stock | 16,579 | $1.89 | $31,334.31 |
DisclosureSEC source: 0001470831-26-000176 · wk-form4_1771452289.xml · nonDerivative · entry 3 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,803 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:04 UTC |
REYNO LEONARDChief Medical Officer
|
Exercise / conversionCommon Stock | 30,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000176 · wk-form4_1771452289.xml · nonDerivative · entry 2 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 14, 2024 and February 18, 2025. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:04 UTC |
Hirsch AndrewDirector · President & CEO
|
Tax withholdingCommon Stock | 39,154 | $1.89 | $74,001.06 |
DisclosureSEC source: 0001470831-26-000177 · wk-form4_1771452294.xml · nonDerivative · entry 3 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,083,991 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:04 UTC |
Hirsch AndrewDirector · President & CEO
|
Exercise / conversionCommon Stock | 81,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000177 · wk-form4_1771452294.xml · nonDerivative · entry 2 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,123,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 15, 2024 and February 18, 2025. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:05 UTC |
Schick KellyChief People Officer
|
Tax withholdingCommon Stock | 7,269 | $1.89 | $13,738.41 |
DisclosureSEC source: 0001470831-26-000178 · wk-form4_1771452301.xml · nonDerivative · entry 5 Schick Kelly · CIK 0001797388 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,881 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 14, 2026 Filed Feb 18, 2026 22:05 UTC |
Schick KellyChief People Officer
|
Exercise / conversionCommon Stock | 20,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000178 · wk-form4_1771452301.xml · nonDerivative · entry 4 Schick Kelly · CIK 0001797388 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 17:05 UTC |
Boyle Scott NChief Business Officer
|
Tax withholdingCommon Stock | 1,735 | $1.89 | $3,279.15 |
DisclosureSEC source: 0001470831-26-000180 · wk-form4_1771452315.xml · nonDerivative · entry 3 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,070 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 17:05 UTC |
Boyle Scott NChief Business Officer
|
Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000180 · wk-form4_1771452315.xml · nonDerivative · entry 2 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 17:05 UTC |
Boyle Scott NChief Business Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000180 · wk-form4_1771452315.xml · nonDerivative · entry 1 Boyle Scott N · CIK 0001913897 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,805 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 100,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 100,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 17:05 UTC |
Mahaney PaigeChief Scientific Officer
|
GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000179 · wk-form4_1771452309.xml · nonDerivative · entry 1 Mahaney Paige · CIK 0002040313 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,356 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:04 UTC |
Mossler MarkChief Accounting Officer
|
GrantCommon Stock | 56,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000174 · wk-form4_1771452272.xml · nonDerivative · entry 1 Mossler Mark · CIK 0001992219 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,184 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 28,490 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 28,490 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 17:04 UTC |
Adams KendraChief Financial Officer
|
Tax withholdingCommon Stock | 1,863 | $1.89 | $3,521.07 |
DisclosureSEC source: 0001470831-26-000175 · wk-form4_1771452283.xml · nonDerivative · entry 3 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,479 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 17:04 UTC |
Adams KendraChief Financial Officer
|
Exercise / conversionCommon Stock | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000175 · wk-form4_1771452283.xml · nonDerivative · entry 2 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 17:04 UTC |
Adams KendraChief Financial Officer
|
GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000175 · wk-form4_1771452283.xml · nonDerivative · entry 1 Adams Kendra · CIK 0001991929 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 402,342 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:04 UTC |
REYNO LEONARDChief Medical Officer
|
GrantCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000176 · wk-form4_1771452289.xml · nonDerivative · entry 1 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 396,382 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:04 UTC |
Hirsch AndrewDirector · President & CEO
|
GrantCommon Stock | 700,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000177 · wk-form4_1771452294.xml · nonDerivative · entry 1 Hirsch Andrew · CIK 0001586707 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,123,145 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 350,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 350,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:05 UTC |
Schick KellyChief People Officer
|
Tax withholdingCommon Stock | 1,735 | $1.89 | $3,279.15 |
DisclosureSEC source: 0001470831-26-000178 · wk-form4_1771452301.xml · nonDerivative · entry 3 Schick Kelly · CIK 0001797388 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,150 F3 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:05 UTC |
Schick KellyChief People Officer
|
Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000178 · wk-form4_1771452301.xml · nonDerivative · entry 2 Schick Kelly · CIK 0001797388 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Reflects the acquisition of shares of Common Stock upon vesting of previously disclosed grants of RSUs. The grants of RSUs were initially reported in Table I of the Forms 4 filed by the Reporting Person on February 15, 2023, February 14, 2024 and February 18, 2025. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 22:05 UTC |
Schick KellyChief People Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001470831-26-000178 · wk-form4_1771452301.xml · nonDerivative · entry 1 Schick Kelly · CIK 0001797388 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308,885 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 100,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 100,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones. Read SEC document |
| January 16, 2026 Filed Jan 16, 2026 21:27 UTC |
REYNO LEONARDChief Medical Officer
|
SaleCommon Stock | 10,000 | $2.22 | $22,200.00 |
DisclosureSEC source: 0001470831-26-000045 · wk-form4_1768598875.xml · nonDerivative · entry 1 REYNO LEONARD · CIK 0001528716 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,382 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.